Literature DB >> 26366391

The CRISPR road: from bench to bedside on an RNA-guided path.

Benjamin Garcia-Bloj1, Colette Moses1, Pilar Blancafort1.   

Abstract

Year:  2015        PMID: 26366391      PMCID: PMC4543326          DOI: 10.3978/j.issn.2305-5839.2015.07.20

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


× No keyword cloud information.
  22 in total

Review 1.  Determining the specificities of TALENs, Cas9, and other genome-editing enzymes.

Authors:  Vikram Pattanayak; John P Guilinger; David R Liu
Journal:  Methods Enzymol       Date:  2014       Impact factor: 1.600

2.  Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity.

Authors:  F Ann Ran; Patrick D Hsu; Chie-Yu Lin; Jonathan S Gootenberg; Silvana Konermann; Alexandro E Trevino; David A Scott; Azusa Inoue; Shogo Matoba; Yi Zhang; Feng Zhang
Journal:  Cell       Date:  2013-08-29       Impact factor: 41.582

3.  Deletions, Inversions, Duplications: Engineering of Structural Variants using CRISPR/Cas in Mice.

Authors:  Katerina Kraft; Sinje Geuer; Anja J Will; Wing Lee Chan; Christina Paliou; Marina Borschiwer; Izabela Harabula; Lars Wittler; Martin Franke; Daniel M Ibrahim; Bjørt K Kragesteen; Malte Spielmann; Stefan Mundlos; Darío G Lupiáñez; Guillaume Andrey
Journal:  Cell Rep       Date:  2015-02-07       Impact factor: 9.423

Review 4.  Genome editing. The new frontier of genome engineering with CRISPR-Cas9.

Authors:  Jennifer A Doudna; Emmanuelle Charpentier
Journal:  Science       Date:  2014-11-28       Impact factor: 47.728

Review 5.  Non-viral vectors for gene-based therapy.

Authors:  Hao Yin; Rosemary L Kanasty; Ahmed A Eltoukhy; Arturo J Vegas; J Robert Dorkin; Daniel G Anderson
Journal:  Nat Rev Genet       Date:  2014-07-15       Impact factor: 53.242

Review 6.  Maximizing mouse cancer models.

Authors:  Kristopher K Frese; David A Tuveson
Journal:  Nat Rev Cancer       Date:  2007-09       Impact factor: 60.716

7.  A mouse model for EML4-ALK-positive lung cancer.

Authors:  Manabu Soda; Shuji Takada; Kengo Takeuchi; Young Lim Choi; Munehiro Enomoto; Toshihide Ueno; Hidenori Haruta; Toru Hamada; Yoshihiro Yamashita; Yuichi Ishikawa; Yukihiko Sugiyama; Hiroyuki Mano
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-08       Impact factor: 11.205

8.  Life in the fast lane: mammalian disease models in the genomics era.

Authors:  Lukas E Dow; Scott W Lowe
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

9.  Simple and rapid in vivo generation of chromosomal rearrangements using CRISPR/Cas9 technology.

Authors:  Rafael B Blasco; Elif Karaca; Chiara Ambrogio; Taek-Chin Cheong; Emre Karayol; Valerio G Minero; Claudia Voena; Roberto Chiarle
Journal:  Cell Rep       Date:  2014-11-13       Impact factor: 9.423

10.  Targeted genomic rearrangements using CRISPR/Cas technology.

Authors:  Peter S Choi; Matthew Meyerson
Journal:  Nat Commun       Date:  2014-04-24       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.